Cancer of unknown primary origin future or investigational therapies

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: ; Roukoz A. Karam, M.D.[2]

Current research involves the application of proteomic and genomic tools to unknown primary cancer.